Patents by Inventor Julian Davies

Julian Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020086993
    Abstract: A novel crystal form of the pharmaceutical compound olanzapine, processes for its preparation and its pharmaceutical use are disclosed.
    Type: Application
    Filed: December 19, 2001
    Publication date: July 4, 2002
    Inventors: Julian Davies, James Edward Gano
  • Patent number: 5958687
    Abstract: The invention relates to a nucleotide sequence coding for a cycloheximide resistance protein sensitive to concatenation of amino acids A, or coding for all or part of said optionally modified concatenation A, in as much as the formed protein confers cycloheximide resistance to a recombinant eucaryotic host transformed by the nucleotide sequence coding for said protein, in conditions appropriate for its production. The invention also relates to a sequence containing the DNA coding for the concatenation A and capable of conferring a high level of resistance to cycloheximide in a given host.
    Type: Grant
    Filed: March 14, 1997
    Date of Patent: September 28, 1999
    Assignee: Institut Pasteur
    Inventors: Pierre Dehoux, Julian Davies
  • Patent number: 5830997
    Abstract: The invention relates to cycloheximide resistance proteins, which are capable of conferring resistance to cycloheximide to cells containing the protein. The invention also relates to fragments or derivatives of cycloheximide proteins which confer cycloheximide resistance and/or are recognized by antibodies specific for the cycloheximide resistance proteins.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: November 3, 1998
    Assignee: Institut Pasteur
    Inventors: Pierre Dehoux, Julian Davies
  • Patent number: 5641674
    Abstract: The invention relates to a nucleotide sequence coding for a cycloheximide resistance protein sensitive to concatenation of amino acids A, or coding for all or part of said optionally modified concatenation A, in as much as the formed protein confers cycloheximide resistance to a recombinant eucaryotic host transformed by the nucleotide sequence coding for said protein, in conditions appropriate for its production. The invention also relates to a sequence containing the DNA coding for the concatenation A and capable of conferring a high level of resistance to cycloheximide in a given host.
    Type: Grant
    Filed: June 9, 1994
    Date of Patent: June 24, 1997
    Assignee: Institut Pasteur
    Inventors: Pierre Dehoux, Julian Davies